Kintara Therapeutics Inc (KTRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KTRA | AZN | AMGN | GILD | VRTX |
| Company | Kintara Therapeutics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.2356 | 90.29 | 326.27 | 121.24 | 449.74 |
| High | 0.2356 | 91.17 | 328.24 | 122.29 | 452.63 |
| Low | 0.2049 | 90.19 | 321.91 | 120.93 | 445.41 |
| Latest | 0.2154 | 90.61 | 324.42 | 121.47 | 447.38 |
| Change | -0.0145 | +0.75 | -1.59 | +0.11 | -2.14 |
| % Change | -6.31% | +0.83% | -0.49% | +0.09% | -0.48% |
| Volume | 3,700,200 | 6,828,500 | 2,669,200 | 5,795,400 | 1,056,900 |
| 20-Day Average Volume | 5,464,335 | 5,873,105 | 2,884,340 | 7,082,875 | 1,380,160 |
| Previous Close | 0.2299 | 89.86 | 326.01 | 121.36 | 449.52 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.1914 | 90.92 | 330.92 | 123.07 | 441.63 |
| 20-Day Raw Stochastic | 70.09% | 39.25% | 35.40% | 31.34% | 62.44% |
| 20-Day Relative Strength | 54.98 | 55.95 | 51.56 | 49.58 | 56.08 |
| Weighted Alpha | -52.80 | +40.72 | +23.01 | +28.26 | +11.16 |
| Today's Opinion | 56% Buy | 88% Buy | 72% Buy | 56% Buy | 72% Buy |
| Previous Opinion | 72% Buy | 88% Buy | 72% Buy | 56% Buy | 56% Buy |
| Last Month's Opinion | 24% Sell | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +22.25% since 10/10/24 | +0.35% since 12/11/25 | +2.22% since 12/11/25 | -1.41% since 12/11/25 | +0.33% since 12/11/25 |
| Low | 0.1762 on 10/11/24 | 89.28 on 12/12/25 | 315.19 on 12/12/25 | 118.17 on 12/16/25 | 444.81 on 12/12/25 |
| High | 0.2399 on 10/15/24 | 91.79 on 12/15/25 | 330.04 on 12/17/25 | 123.63 on 12/12/25 | 459.05 on 12/16/25 |
| 1-Month | |||||
| %Chg | +12.72% since 09/17/24 | +1.18% since 11/18/25 | -5.69% since 11/18/25 | -4.49% since 11/18/25 | +2.72% since 11/18/25 |
| Low | 0.1580 on 09/20/24 | 88.41 on 11/20/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 418.53 on 11/19/25 |
| High | 0.2399 on 10/15/24 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | -20.72% since 07/17/24 | +17.57% since 09/18/25 | +17.62% since 09/18/25 | +6.91% since 09/18/25 | +15.57% since 09/18/25 |
| Low | 0.1553 on 09/12/24 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 0.2839 on 07/18/24 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +107.51% since 04/17/24 | +28.05% since 06/18/25 | +12.01% since 06/18/25 | +12.47% since 06/18/25 | -0.23% since 06/18/25 |
| Low | 0.1010 on 04/18/24 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 0.4170 on 05/30/24 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,913 | 278,694,144 | 175,550,208 | 150,568,928 | 114,051,760 |
| Shares Outstanding, K | 55,305 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -8,320,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -2,320,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.82 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.05 on 05/14/24 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 11/11/24 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.99 | 14.94 | 14.50 | 29.72 |